You have 9 free searches left this month | for more free features.

Busulfan

Showing 1 - 25 of 660

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

Active, not recruiting
  • Myeloid Malignancies
  • +4 more
  • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
  • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 25, 2022

Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 14, 2022

Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

Recruiting
  • Cancer
  • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
  • Jinan, Shandong, China
    Shandong Provincial Qianfoshan Hospital
Jul 18, 2022

Acute Lymphoblastic Leukemia Trial in Seoul (Busulfan)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Busulfan
  • Seoul, Daehangno, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
Jun 15, 2021

Intravenous Busulfan And Fludarabine Myeloablative Conditioning

Completed
  • Acute Myeloid Leukemia
  • +3 more
    • (no location specified)
    Mar 16, 2022

    Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Enrolling by invitation
    • Severe Combined Immune Deficiency (SCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

    Completed
    • Disorder Related to Bone Marrow Transplantation
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Nov 18, 2021

    Genetic Rare Disease Trial in Seoul (Busulfan)

    Recruiting
    • Genetic Rare Disease
    • Busulfan
    • Seoul, Daehangno, Jongno-gu, Korea, Republic of
      Seoul National University Hospital
    Mar 28, 2021

    Leukemia Trial (biological, drug, procedure, radiation)

    Active, not recruiting
    • Leukemia
    • aldesleukin
    • +9 more
    • (no location specified)
    Feb 17, 2022

    Multiple Myeloma Trial in Maywood (Carfilzomib, Busulfan IV, Melphalan IV)

    Recruiting
    • Multiple Myeloma
    • Maywood, Illinois
      Loyola University Medical Center
    Apr 23, 2021

    Leukemia, MDS Trial (drug, procedure, radiation)

    Active, not recruiting
    • Leukemia
    • Myelodysplastic Syndromes
    • busulfan
    • +7 more
    • (no location specified)
    Feb 17, 2022

    Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

    Recruiting
    • Chronic Granulomatous Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 23, 2022

    Acute Leukemia Trial in Shanghai (Busulfan)

    Recruiting
    • Acute Leukemia
    • Busulfan
    • Shanghai, China
      Blood & Marrow Transplantation Center, RuiJin Hospital
    May 19, 2021

    Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

    Recruiting
    • Leukemia, Acute Lymphoblastic
    • +5 more
    • Saint Petersburg, Russian Federation
      RM Gorbacheva Research Institute
    Jun 21, 2021

    Polymorphisms and Busulfan Pharmacokinetic Study

    Recruiting
    • Children Who Receive a Stem Cell Transplantation With Busulfan IV
      • Calgary, Alberta, Canada
      • +3 more
      Apr 27, 2021

      Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Stem Cell Transplantation, Autologous Hematopoietic Stem Cell

      Recruiting
      • Hematopoietic Stem Cell Transplantation
      • +2 more
      • GSTA1 genotyping
      • Geneva, Switzerland
        Hôpitaux Universitaires de Genève
      Jul 30, 2021

      T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)

      Recruiting
      • T-cell Non-Hodgkin Lymphoma
      • Lymphoma, Extranodal NK-T-Cell
      • Busan, Korea, Republic of
      • +1 more
      Aug 17, 2022

      Myelodysplastic Syndrome, Leukemia, Acute Myeloid Leukemia Trial in Houston (Busulfan, Fludarabine)

      Completed
      • Myelodysplastic Syndrome
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jan 12, 2021

      Target Busulfan Exposure in Children With HSCT in China

      Recruiting
      • Hematopoietic Stem Cell Transplantation
      • Busulfan
      • Suzhou, Jiangsu, China
        the First Affiliated Hospital of Soochow University
      Mar 8, 2021

      Acute Leukemia, Mielodysplasic Syndrome, Myeloproliferative Tumor Trial (Busulfan Injection)

      Not yet recruiting
      • Acute Leukemia
      • +2 more
      • Busulfan Injection
      • (no location specified)
      Nov 16, 2020

      Bone Marrow Disease Trial (Saliva monitoring)

      Completed
      • Bone Marrow Disease
      • Saliva monitoring
      • (no location specified)
      May 8, 2021

      HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)

      Active, not recruiting
      • HIV
      • SB-728mR-HSPC Infusion 3 days following busulfan conditioning
      • Duarte, California
      • +4 more
      Mar 7, 2022

      GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)

      Recruiting
      • GATA2
      • +2 more
      • Allogeneic HSCT
      • +8 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

      Recruiting
      • Primary CNS Lymphoma
      • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
      • Moscow, Russian Federation
        Nathional Medical Research Center for Hematology
      Jun 16, 2022

      Refractory Brain Tumors Trial (Busulfan)

      Withdrawn
      • Refractory Brain Tumors
      • Busulfan
      • (no location specified)
      Aug 3, 2020